Fruit juice, a popular drink popular with teens and adults, is now the subject of an investigation from the Food and Drug Administration after an FDA spokesperson reported a customer in Illinois had purchased fruit juice tainted with a banned stimulant.
According to the FDA spokesperson, the customer bought juice that contained the stimulant benzosalbutamide.
Benzosalbuttamide is banned by the US Food and Drugs Administration (FDA) for the treatment of anxiety and panic disorder.
The stimulant, found in Benzo’s, is also known as methylamphetamine, methamphetamine, methamphetamine hydrochloride, and methylamphetamine sulfate.
According to the manufacturer, the stimulants are not a controlled substance.
However, the FDA’s warning letter said that the customer also purchased an over-the-counter version of Benzosale, a generic version of benzosale that was sold in other states.
The FDA says the product was not sold under its original name, but that the consumer purchased it as a generic and used it to get the drug.
The company that sells the over-counter product in Illinois did not respond to a request for comment.
The product has been linked to the deaths of three people in California and the U.K.
The Illinois customer, who the FDA said had been on a medication-assisted treatment program, purchased Benzosalesalbutamide at Costco, a Costco affiliate, according to the letter.
The FDA’s letter says the store notified the FDA and the Department of Health and Human Services.
Benzosale is an anti-anxiety drug.
A study published in the journal Neurology found that patients on benzodiazepines had a significantly higher risk of death than patients on placebo.
Benzo doses have been linked in at least one death to increased risk of dementia.
The Food and Health Department’s Office of Drug Control and Regulatory Affairs also confirmed to ABC News that it received the FDA warning letter and will investigate whether the product in question violates the Food, Drug, and Cosmetic Act (FDCA).
The FDA sent a letter to the customer’s pharmacy informing the customer of the FDA warnings, but it did not indicate what steps were being taken.
The letter also did not specify what actions the company may be taking to address the safety concerns.
The letter did not name the store.
The Costco representative, who requested anonymity, said in an email that the company “will be cooperating with the FDA in the investigation.”
The FDA said it is not responsible for any health consequences or injuries that may result from the sale of the product, but noted that the FDA has been working with other federal, state, and local agencies to identify and investigate cases of over-prescribing of the drug, and to make it safer for the consumer.
The Associated Press contributed to this report.